Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064

Expensive Underperformer

Download real time

530.30 -5.50 (-1.03%)

New 52W Low in past week

275.6K NSE+BSE Volume

NSE 15 Dec, 2025 3:31 PM (IST)

20,287.5

Market Cap

High in industry

-

Beta 1Year

Very Low volatility

Cohance Lifesciences Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for COHANCE, BSE:543064 Cohance Lifesciences Ltd.

VOTE: Is Suven Pharmaceuticals Ltd. worth buying?

35 Votes:

Buy 68.57%

Sell 17.14%

Hold 14.29%

RESEARCH REPORTS

Sell SEE REPORTS >

Buy SEE REPORTS >